ArticleMediators of inflammation2026
Deletion of Circadian Rhythms Gene BMAL1 Impairs the Intestinal Epithelial Barrier and Exacerbates Intestinal Inflammation by Inducing Pyroptosis.
Article in Mediators of inflammation, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Deletion of Circadian Rhythms Gene BMAL1 Impairs the Intestinal Epithelial Barrier and Exacerbates Intestinal Inflammation by Inducing Pyroptosis.Mediators of inflammation · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
Abstract
The circadian clock plays a crucial role in the pathogenesis of various inflammatory and autoimmune diseases, including ulcerative colitis (UC). Deletion of the core transcription factor BMAL1 exacerbated the severity of colitis. However, the underlying molecular mechanisms of BMAL1 in UC remain unclear. We found that BMAL1 was downregulated in UC tissues and in LPS-induced MODE-K cells, whereas CXCL1 was highly expressed. Overexpression of BMAL1 reduced LPS-induced pyroptosis in MODE-K cells and restoring the expression of ZO-1, Claudin-1, and Occludin, thereby improving intestinal epithelial barrier function. Mechanistically, BMAL1 can negatively regulate the CXCL1 expression by inhibiting the activity of its promoter. Additionally, proteomics analysis identified MEF2A as a downstream protein of BMAL1. The protective effect of BMAL1 on MODE-K cells was achieved through direct negative regulation of CXCL1 or indirect negative regulation of MEF2A expression. Thus, BMAL1 plays a protective role in maintaining the integrity of the intestinal epithelial barrier and represents a potential therapeutic target for UC treatment.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.